Detalhe da pesquisa
1.
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Nature
; 594(7863): 418-423, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953400
2.
Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma.
Oncologist
; 29(6): e811-e821, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470950
3.
Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06).
BMC Cancer
; 24(1): 252, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38395832
4.
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study.
Gastric Cancer
; 27(1): 118-130, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906316
5.
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma.
J Am Acad Dermatol
; 87(5): 989-996, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068115
6.
Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations.
Invest New Drugs
; 39(5): 1366-1374, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723724
7.
Objectively measured physical activity during chemotherapy in colon cancer patients.
Support Care Cancer
; 28(6): 2597-2604, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31612283
8.
Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer.
Gastric Cancer
; 22(6): 1153-1163, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31098863
9.
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
Ann Surg Oncol
; 25(11): 3222-3230, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30051367
10.
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy.
BMC Cancer
; 18(1): 1116, 2018 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30442107
11.
The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status.
Gastric Cancer
; 21(2): 213-224, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643145
12.
Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11.
Gastric Cancer
; 21(5): 802-810, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29372461
13.
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
Gastric Cancer
; 21(5): 819-830, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427038
14.
Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Ann Surg Oncol
; 24(1): 227-235, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27699609
15.
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
BMC Cancer
; 17(1): 615, 2017 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28865435
16.
Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
Br J Cancer
; 115(1): 25-33, 2016 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27228287
17.
Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.
Ann Surg
; 263(1): 96-102, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25575260
18.
Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
Ann Surg Oncol
; 23(3): 928-35, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26514121
19.
Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.
Ann Surg Oncol
; 22(1): 224-31, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25081339
20.
PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer.
Oncology
; 88(2): 76-85, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25300346